Term
| Differential diagnosis for community acquired acute airspace pneumonia: |
|
Definition
| Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Klebsiella pneumoniae, Pseudomons aeruginosa, Legionella, Mycobacterium tuberculosis, Coccidioides, Moraxella catarrhalis |
|
|
Term
| Differential diagnosis for community acquired acute interstitial pneumonia: |
|
Definition
Chlamydophila
Mycoplasma
Influenza
Parainfluenza
RSV
Other resp viruses
Herpes viruses |
|
|
Term
| Differential diagnosis for hospital acquired acute airspace pneumonia: |
|
Definition
Staph. aureus
Enterobacteriaceae
Pseudomonas aerug.
Other Gram negative rods |
|
|
Term
| Stages of airspace pneumonia: |
|
Definition
| Acute congestion (24 hrs), red hepatization (2-3 days), gray heptization (2-3 days), resolution (weeks) |
|
|
Term
| Microscopic appearance of interstitial pneumonitis: |
|
Definition
| Edematous alveolar septae, WBC infiltrate, type 2 alveolar cell hyperplasia, clear alveolar space, hyaline membranes, microorganisms |
|
|
Term
| Agents that cause milliary pneumonia: |
|
Definition
Coccidioides
Histoplasmosis
Herpesviruses
Hematogenous TB |
|
|
Term
| Possible complications associated with airspace pneumonia: |
|
Definition
| Pleural effusion, lung abcess, necrosis, ARDS |
|
|
Term
| Possible complications associated with interstitial pneumonia: |
|
Definition
Bacterial superinfection
Acute Respiratory Distress Syndrome |
|
|
Term
| Types of pleural effusion: |
|
Definition
| Uncomplicated (no bacteria), complicated (more significant effusion), empyema (bacteria and WBC's in pleural space) |
|
|
Term
| Most common causes of cavitary pneumonia: |
|
Definition
Mycobacterium tuberculosis
Coccidioides
Blasto
Histo
Actinomyces |
|
|
Term
| Pneumonia with rust colored sputum: |
|
Definition
|
|
Term
| Pneumonia with "currant jelly" sputum: |
|
Definition
|
|
Term
| Pneumonia with foul smelling sputum: |
|
Definition
| mixed anaerobes (aspiration) |
|
|
Term
| Clinical presentation of airspace pneumonia: |
|
Definition
| fever, chills, cough, sputum production, pleuritic chest pain, shortness of breath, tachypnea, lung crackles, consolidation |
|
|
Term
| Signs of lung consolidation: |
|
Definition
vesicular breath sounds become tubular
increased voice transmission
egophony (ee to ay)
tactile fremitus |
|
|
Term
| Clinical presentation of interstitial pneumonia: |
|
Definition
| fever (variable), cough (variable), sputum - absent, clear or watery, DOE, appear less ill than airspace pneumonia, lung crackles, wheezing |
|
|
Term
| Differential diagnosis for chronic airspace pneumonia: |
|
Definition
M. tuberculosis
Coccidioides
Blastomyces
Cryptococcus
Actinomyces
Nocardia |
|
|
Term
| Differential diagnosis for chronic intersitial pneumonia: |
|
Definition
Pneumocystis
M. avium complex
Histoplasma |
|
|
Term
| Infectious agents associated with COPD/smoking: |
|
Definition
H.influenzae, M.catarrhalis, Strep pneumo,
Pseudomonas aeruginosa (severe COPD). |
|
|
Term
| CF / Bronchiectasis: associated agents of pneumonia |
|
Definition
Staph aureus, Pseudomonas aeruginosa,
Burkholderia cepacia |
|
|
Term
| Alcoholism: associated agents of pneumonia |
|
Definition
Klebsiella pneumoniae, Strep pneumo,
oral anaerobes, Mycobacterium tuberculosis |
|
|
Term
| HIV/AIDS: associated agents of pneumonia |
|
Definition
Strep pneumo, Mycobacterium tuberculosis,
Pneumocystis, Cryptococcus, P.aeruginosa |
|
|
Term
| immunocompromise: associated agents of pneumonia |
|
Definition
Aspergillus (Neutropenia / Tx), Nocardia
(Tx / Steroids), M. tb (TNFa inhibitor), CMV (Tx) |
|
|
Term
| Necrotizing pneumonia after Influenza = |
|
Definition
| bacterial super infection – staph or strep |
|
|
Term
| Pneumonia with cold agglutinins = |
|
Definition
| IgM that precipitates RBC’s at low temp - mycoplasma |
|
|
Term
| Pneumonia with erythema nodosum = |
|
Definition
| inflammatory infiltrate of subQ - Cocci |
|
|
Term
| Pneumonia in pregnancy with vesicular rash- |
|
Definition
|
|
Term
| Pneumonia in a patient with a pet parakeet |
|
Definition
|
|
Term
|
Definition
|
|
Term
| NSCLC, Stage I, treatment strategy: |
|
Definition
|
|
Term
| Stage II, NSCLC treatment strategy: |
|
Definition
| surgery followed by chemo (cisplatin + vinorelbine) |
|
|
Term
| Stage IIIa, NSCLC treatment strategy: |
|
Definition
| chemotherapy and/or radiation, sometimes followed by surgery |
|
|
Term
| Stage IIIb, NSCLC treatment strategy: |
|
Definition
| chemotherapy and/or radiation, NO surgery |
|
|
Term
| Stage IV, NSCLC treatment strategy: |
|
Definition
| Chemotherapy (platinum + second drug), targeted therapy |
|
|
Term
| limited, SCLC treatment strategy: |
|
Definition
| chemo (cisplatin + etoposide), radiation, prophylactic cranial irradiation |
|
|
Term
| extensive, SCLC treatment strategy: |
|
Definition
| chemo (cisplatin + etoposide OR irinotecan), NO radiation |
|
|
